Learn More
Apexbio Technology LLC BMS-754807(Synonyms: BMS754807, IGF-1R/InsR inhibitor BMS-754807, IGF-1R Inhibitor BMS-754807, BMS 754807), 100mg, CAS: 1001350-96-4.

Supplier: Apexbio Technology LLC A1185100
BMS-754807 (CAS 1001350-96-4) is a small molecule inhibitor targeting insulin-like growth factor 1 receptor (IGF-1R) and insulin receptor (IR) Acting as an ATP-competitive antagonist it directly interferes with the catalytic kinase domains of IGF-1R/IR thereby disrupting their enzymatic activities In vitro studies demonstrated potent antiproliferative activity against various cancer cell lines including mesenchymal hematopoietic and epithelial tumors (IC50 ranging from 5 to 365 nmol/L) Furthermore evidence from apoptosis assays in human rhabdomyosarcoma cells indicates BMS-754807 can induce apoptosis characterized by increased caspase cleavage and poly(ADP-ribose) polymerase (PARP) fragmentation This compound is primarily applied in oncology research aimed at elucidating IGF-1R/IR signaling pathways
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.